Wu YL - Search Results

1

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study.

Zhong WZ, Chen KN, Chen C, Gu CD, Wang J, Yang XN, Mao WM, Wang Q, Qiao GB, Cheng Y, Xu L, Wang CL, Chen MW, Kang X, Yan W, Yan HH, Liao RQ, Yang JJ, Zhang XC, Zhou Q, Wu YL. Zhong WZ, et al. Among authors: wu yl. J Clin Oncol. 2019 Sep 1;37(25):2235-2245. doi: 10.1200/JCO.19.00075. Epub 2019 Jun 13. J Clin Oncol. 2019. PMID: 31194613 Clinical Trial.

2

[The application of needle video-assisted thoracoscopic biopsy in pathologic diagnosis and staging for advanced lung cancer].

Gu LJ, Wu YL, Feng WN, Weng YM, Cheng C, Zhong WZ, Huang SH. Gu LJ, et al. Among authors: wu yl. Zhonghua Jie He He Hu Xi Za Zhi. 2003 Jul;26(7):396-9. Zhonghua Jie He He Hu Xi Za Zhi. 2003. PMID: 12921642 Chinese.

3

[Effects of neoadjuvant chemotherapy on estrogen and progesterone receptors and HER-2 in breast cancer].

Zhao J, Wu YL, Wang YD, Zhao GR, Wang J. Zhao J, et al. Among authors: wu yl. Di Yi Jun Yi Da Xue Xue Bao. 2004 Dec;24(12):1437-9. Di Yi Jun Yi Da Xue Xue Bao. 2004. PMID: 15604081 Chinese.

4

[Treatment of non-small-cell lung cancer with paraplatin given by two different dosage calculation methods].

Gu LJ, Wu YL, Feng WN, Weng YM, Cheng C, Zhong WZ, Huang SH, Yang P. Gu LJ, et al. Among authors: wu yl. Zhonghua Zhong Liu Za Zhi. 2005 Jan;27(1):29-32. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15771794 Clinical Trial. Chinese.

5

[Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].

Cheng C, Wu YL, Gu LJ, Chen G, Weng YM, Feng WN, Zhong WZ. Cheng C, et al. Among authors: wu yl. Ai Zheng. 2005 Jul;24(7):846-9. Ai Zheng. 2005. PMID: 16004813 Clinical Trial. Chinese.

6

[Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].

Qiao GB, Wu YL, Ou W, Yang XN, Zhong WZ, Lin JY, Zhao J, Xie D, Guan XY. Qiao GB, et al. Among authors: wu yl. Zhonghua Wai Ke Za Zhi. 2005 Jul 15;43(14):913-7. Zhonghua Wai Ke Za Zhi. 2005. PMID: 16083620 Chinese.

7

Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma.

Tai AL, Sham JS, Xie D, Fang Y, Wu YL, Hu L, Deng W, Tsao GS, Qiao GB, Cheung AL, Guan XY. Tai AL, et al. Among authors: wu yl. Cancer. 2006 Jan 1;106(1):146-55. doi: 10.1002/cncr.21581. Cancer. 2006. PMID: 16329133 Free article.

8

[Relationship of the curative effects of gefitinib on non-small cell lung carcinoma to gender and to epithelial growth factor receptor status].

Xu CR, Lin JY, Wang Z, Zhou Q, Zhang GC, Wang K, Yang XN, Chen G, Yang JJ, Huang YJ, Liao RQ, Wu YL. Xu CR, et al. Among authors: wu yl. Zhonghua Yi Xue Za Zhi. 2006 Oct 10;86(37):2606-10. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17198584 Chinese.

9

Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial.

Huang YJ, Wu YL, Xie SX, Yang JJ, Huang YS, Liao RQ. Huang YJ, et al. Among authors: wu yl. Chin Med J (Engl). 2007 Mar 20;120(6):458-62. Chin Med J (Engl). 2007. PMID: 17439736 Clinical Trial.

10

[Gefitinib target treatment in non-small cell lung cancer].

Wu YL, Yang JJ, Lin JY, Huang YJ, Liao RQ, Huang YS, Zhou Q, Xu CR, Wang Z. Wu YL, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Feb;30(2):98-102. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 17445469 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,375 results

Search Page

Filters